top of page
THE POLYKYE PLATFORM
PolyKye AI is Build for Biological Complexity
Complex diseases rarely follow a single pathway. Yet modern drug discovery is still largely built around single targets, isolated datasets, and fragmented development systems.
Canurta is exploring botanicals for their potential to act across multiple biological pathways, opening new possibilities for how we develop medicines.
Platform
AI Built for Biological Complexity
Polykye AI supports discovery across multi-pathway biology, compound interactions, and human outcome feedback.
01
Connect the Evidence
Generate proprietary therapeutic insights from complex natural molecules. Connect composition, product quality and response evidence.
02
Understand Response
Capture human outcomes to continuously improve the system. Use response patterns to inform formulations and trial design
03
Personalize over Time
Turn insights into reproducible, validated medicines, products, and custom formulations. Aim for clinician-guided matching as individual needs evolve.
Three Engines. One Vision for Adaptive Medicine.
Canurta brings together therapeutic development, commercial products, and predictive intelligence. Together, they connect complex natural molecules with human outcomes, turning evidence from products in market into insights for the next generation of botanical medicines.
Therapeutic Engine
Clinical development of botanical therapeutics for complex disease.
Commercial + Learning Engine
Bringing breakthrough consumer health products to market.
PolyKye AI
Intelligence Engine
AI-enabled discovery and formulation for multi-target botanical biology.
News
Dive into the Latest Developments
It has been a while since we have spoken. I am sorry about that — life at Canurta over the past 6 months has been the most trying experience..
Cartilage damage is difficult to reverse, making early protection an important goal in joint health research...
A newly released preprint from Canruta's Bioinformatics team, with contributions from collaborators at Washington State University and..
A newly published peer-reviewed study, "Preclinical study of cannflavins A and B action against glioblastoma cells", evaluates the..
Dual Relief Drops™ and Dual Relief Drops™ Extra Strength are now available for purchase in the USA.
Ecosystem Partners
Contact Us
Have a question or opportunity in mind? We’d be glad to hear from you.
bottom of page